For IPO Boutique's "scale of 1 to 5" BUY rating on Thar Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
About Thar Pharmaceuticals, Inc. (adapted from Thar Pharmaceuticals, Inc. prospectus): They are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, oral therapies designed to solve clinical limitations of existing intravenous-only therapies for serious and life threatening conditions.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "THAR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
